会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 94. 发明授权
    • Product and process for T cell regulation
    • T细胞调节的产物和方法
    • US5820866A
    • 1998-10-13
    • US207481
    • 1994-03-04
    • John W. KapplerPhilippa Marrack
    • John W. KapplerPhilippa Marrack
    • C12N15/09A61K35/12A61K35/18A61K39/00A61K48/00A61P37/00C07K14/47C07K14/74C07K14/77C07K14/80C07K19/00C12N5/10C12N15/85A61K39/385
    • C07K14/80C07K14/70539C07K14/77C12N15/8509A01K2217/05A01K2217/30A01K2267/0325A61K48/00C07K2319/00C12N2799/026
    • The present invention relates to a product and process for regulating the activity of T cells using major histocompatibility complexes (MHC) stably linked to antigenic peptides. Disclosed is an antigenic peptide covalently linked to a major histocompatibility complex (MHC) protein by a novel linker, thereby enabling the formation of a stable peptide-MHC complex, alone or in combination with additional MHC protein chains, capable of being recognized by a T cell receptor (TCR). Also disclosed is a nucleic molecule having a sequence encoding a Peptide-L-MHC molecule comprising an antigenic peptide joined by a linker to an MHC segment. The invention is additionally directed to formulations comprising an antigenic peptide joined by a linker to an MHC segment anchored in a lipid-containing substrate. Pharmaceutical reagents are also disclosed which contain an antigenic peptide joined by a linker to an MHC segment combined with a suitable carrier that is capable of presenting the Peptide-L-MHC molecule so that it is capable of being recognized by a T cell receptor.
    • 本发明涉及使用与抗原肽稳定连接的主要组织相容性复合物(MHC)来调节T细胞的活性的产物和方法。 公开了通过新的接头共价连接到主要组织相容性复合物(MHC)蛋白的抗原肽,从而能够单独或与额外的MHC蛋白链组合形成稳定的肽-MHC复合物,其能够被T 细胞受体(TCR) 还公开了具有编码肽-L-MHC分子的序列的核酸分子,其包含通过接头连接到MHC片段的抗原肽。 本发明另外涉及包含通过接头连接到锚定在含脂质底物中的MHC区段的抗原肽的制剂。 还公开了药物试剂,其含有通过接头连接到与能够呈递肽-L-MHC分子的合适载体的MHC区段的抗原肽,使得其能够被T细胞受体识别。